View software available in the Integrated Systems Biology and AI — Tailored Pharmacology and Precision Medicine Lab led by Hu ...

Researchers have successfully employed an algorithm to identify potential mutations which increase disease risk in the noncoding regions our DNA, which make up the vast majority of the human genome.

Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...

A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...

The incidence of Human Papillomavirus (HPV)–associated oropharyngeal cancers—tumors of the back of the mouth and throat—is ...

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal cancer tumors of the back of the mouth and throat is rising. If caught early, ...

Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World Health Organization standards, the abnormal activation of oncogene FOXR2 only ...

A new study has revealed that FOXR2 activation occurs in multiple brain tumor types, not just CNS neuroblastoma. This discovery could improve the diagnosis, prognosis and treatment of brain tumors.

Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World ...

Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World ...

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked.

A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...